BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 17714744)

  • 1. CB1 receptor-dependent and -independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN 55,212-2.
    Németh B; Ledent C; Freund TF; Hájos N
    Neuropharmacology; 2008 Jan; 54(1):51-7. PubMed ID: 17714744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers.
    Hájos N; Freund TF
    Neuropharmacology; 2002 Sep; 43(4):503-10. PubMed ID: 12367597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid receptor modulation of synapses received by cerebellar Purkinje cells.
    Takahashi KA; Linden DJ
    J Neurophysiol; 2000 Mar; 83(3):1167-80. PubMed ID: 10712447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons.
    Huang CC; Lo SW; Hsu KS
    J Physiol; 2001 May; 532(Pt 3):731-48. PubMed ID: 11313442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CB(1) cannabinoid receptors inhibit the glutamatergic component of KCl-evoked excitation of locus coeruleus neurons in rat brain slices.
    Mendiguren A; Pineda J
    Neuropharmacology; 2007 Feb; 52(2):617-25. PubMed ID: 17070872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species and strain differences in the expression of a novel glutamate-modulating cannabinoid receptor in the rodent hippocampus.
    Hoffman AF; Macgill AM; Smith D; Oz M; Lupica CR
    Eur J Neurosci; 2005 Nov; 22(9):2387-91. PubMed ID: 16262678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors.
    Hoffman AF; Laaris N; Kawamura M; Masino SA; Lupica CR
    J Neurosci; 2010 Jan; 30(2):545-55. PubMed ID: 20071517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum.
    Gerdeman G; Lovinger DM
    J Neurophysiol; 2001 Jan; 85(1):468-71. PubMed ID: 11152748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors.
    Melis M; Pistis M; Perra S; Muntoni AL; Pillolla G; Gessa GL
    J Neurosci; 2004 Jan; 24(1):53-62. PubMed ID: 14715937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses.
    Ohno-Shosaku T; Tsubokawa H; Mizushima I; Yoneda N; Zimmer A; Kano M
    J Neurosci; 2002 May; 22(10):3864-72. PubMed ID: 12019305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices.
    Ameri A; Wilhelm A; Simmet T
    Br J Pharmacol; 1999 Apr; 126(8):1831-9. PubMed ID: 10372827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid-1 (CB1) receptors regulate colonic propulsion by acting at motor neurons within the ascending motor pathways in mouse colon.
    Sibaev A; Yüce B; Kemmer M; Van Nassauw L; Broedl U; Allescher HD; Göke B; Timmermans JP; Storr M
    Am J Physiol Gastrointest Liver Physiol; 2009 Jan; 296(1):G119-28. PubMed ID: 19033531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens.
    Robbe D; Alonso G; Duchamp F; Bockaert J; Manzoni OJ
    J Neurosci; 2001 Jan; 21(1):109-16. PubMed ID: 11150326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling.
    Fukudome Y; Ohno-Shosaku T; Matsui M; Omori Y; Fukaya M; Tsubokawa H; Taketo MM; Watanabe M; Manabe T; Kano M
    Eur J Neurosci; 2004 May; 19(10):2682-92. PubMed ID: 15147302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission.
    Haller J; Mátyás F; Soproni K; Varga B; Barsy B; Németh B; Mikics E; Freund TF; Hájos N
    Eur J Neurosci; 2007 Apr; 25(8):2445-56. PubMed ID: 17445240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid-induced presynaptic inhibition of glutamatergic EPSCs in substantia gelatinosa neurons of the rat spinal cord.
    Morisset V; Urban L
    J Neurophysiol; 2001 Jul; 86(1):40-8. PubMed ID: 11431486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute ethanol suppresses glutamatergic neurotransmission through endocannabinoids in hippocampal neurons.
    Basavarajappa BS; Ninan I; Arancio O
    J Neurochem; 2008 Nov; 107(4):1001-13. PubMed ID: 18796007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus.
    Takahashi KA; Castillo PE
    Neuroscience; 2006; 139(3):795-802. PubMed ID: 16527424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid-induced hyperphagia: correlation with inhibition of proopiomelanocortin neurons?
    Ho J; Cox JM; Wagner EJ
    Physiol Behav; 2007 Oct; 92(3):507-19. PubMed ID: 17532014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.
    Hájos N; Ledent C; Freund TF
    Neuroscience; 2001; 106(1):1-4. PubMed ID: 11564411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.